[1]权海侠 闫妮.每日膳食钾摄入量与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(03):154-158.[doi:10.3760/cma.j.issn.1673-4157.2020.03.003]
　Quan Haixia,Yan Ni.Correlation between daily dietary potassium intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2020,40(03):154-158.[doi:10.3760/cma.j.issn.1673-4157.2020.03.003]
点击复制

每日膳食钾摄入量与代谢综合征的相关性()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
40
期数:
2020年03期
页码:
154-158
栏目:
论著
出版日期:
2020-05-20

文章信息/Info

Title:
Correlation between daily dietary potassium intake and metabolic syndrome
作者:
权海侠1 闫妮2
1扶风县人民医院内分泌科,宝鸡 722299; 2陕西省人民医院内分泌科,西安 710068
Author(s):
Quan Haixia1;  Yan Ni2
1Department of Endocrinology, Fufeng County People's Hospital, Baoji 722299, China; 2Department of Endocrinology, Shanxi Provincial People's Hospital, Xi'an 710068, China
关键词:
膳食钾摄入量;  代谢综合征
Keywords:
Dietary potassium intake;  Metabolic syndrome
DOI:
10.3760/cma.j.issn.1673-4157.2020.03.003
摘要:
目的 分析每日膳食钾摄入量与代谢综合征(MS)的关系。方法 纳入2015年3月至2019年3月2 248名在扶风县人民医院体检者为研究对象,使用连续3 d持续24 h膳食回顾法获得个人膳食钾的摄入量。同时进行体格检查和清晨空腹血样采集,根据膳食钾摄入量(mg/d)分为亚组,使用多因素logistic回归分析,探讨膳食钾摄入量与MS的相关性。结果 所有调查对象平均每日膳食钾摄入量为(2 432.87±31.43)mg,男性显著高于女性(t=30.281, P=0.000)。男性吸烟比例、饮酒比例、腰围、总胆固醇、低密度脂蛋白-胆固醇、高密度脂蛋白-胆固醇水平显著高于女性(χ2=467.068、478.304; t=16.726、14.844、4.313、5.267, P均<0.05); 而女性MS患病率、腹型肥胖比例、高血压、糖尿病、高甘油三酯血症、低高密度脂蛋白-胆固醇血症及甘油三酯水平显著高于男性(χ2=4.700、12.005、30.280、5.170、5.946、 3.543, t=6.116,P均<0.05)。Logistic回归分析显示,男性调查对象的每日膳食钾摄入量和MS发病率间无显著相关关系(OR=1.38,95% CI: 0.68～2.79, P=0.364)。当女性调查对象每日膳食钾摄入量少于3 600 mg时,每增加1 000 mg/d,其MS发病风险降低12%(OR=0.88, 95% CI: 0.83～0.98, P=0.002)。每日膳食钾摄入量增加时,MS的5个组成因素(腹型肥胖、高血糖、高血压、高甘油三酯血症、低高密度脂蛋白-胆固醇血症)的发生均显著下降(χ2=75.02、22.09、146.00、25.54、14.68,P均<0.05),平均每个患者所患MS组成因素个数也显著减小(F=3 119,P=0.000)。结论 每日膳食钾摄入量与女性MS的发病风险呈负相关,高钾膳食是MS 的保护因素。
Abstract:
Objective To analyze the relationship between daily dietary potassium intake and metabolic syndrome(MS).Methods A total of 2 248 eligible participants in the examination center of Fufeng County People's Hospital from March 2015 to March 2019 were enrolled in this survey. Individual dietary potassium intake was obtained using a continuous 3 d continuous 24 h dietary review method. Physical examination and fasting blood samples were collected at the same time, and the correlation between daily dietary potassium intake and MS was analyzed using multivariate logistic regression analysis.Results The average dietary potassium intake of all the respondents was(2 432.87±31.43)mg/d, which was significantly higher in men than that in women(t=30.281, P=0.000). The smoking ratio, drinking ratio, waist circumference, total cholesterol, low-density lipoprotein-cholesterol and high density lipoprotein-cholesterol in men were significantly higher than those in women(χ2=467.068, 478.304; t=16.726, 14.844, 4.313, 5.267, all P<0.05). The prevalence of MS, the proportion of abdominal obesity, hypertension, diabetes, hypertriglyceridemia, low-density lipoprotein-cholesterol and triglyceride levels in women were significantly higher than those in men(χ2=4.700, 12.005, 30.280, 5.170, 5.946, 3.543; t=6.116, all P<0.05). Logistic regression analysis showed that there was no significant correlation between daily dietary potassium intake and the incidence of MS among male respondents(OR=1.38, 95% CI: 0.68-2.79, P=0.364). When the female subject's daily dietary potassium intake was less than 3 600 mg, each increased intake of 1 000 mg/d reduced the risk of MS by 12%(OR=0.88, 95% CI: 0.83-0.98, P=0.002). When daily dietary potassium intake increased, the incidence of the five constituent factors of MS(abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low high-density lipoprotein-cholesterol)decreased significantly(χ2 = 75.02, 22.09, 146.00, 25.54, 14.68, all P<0.05), the number of MS constituents per patient also decreased significantly(F=3 119.00, P=0.000).Conclusion Daily dietary potassium intake is negatively correlated with the risk of MS in women, and high potassium diet is protective factor for MS.

参考文献/References:

[1] 何宇纳, 赵文华, 赵丽云, 等. 中国2010-2012年成年人代谢综合征流行特征[J]. 中华流行病学杂志, 2017,38(2):212-215.DOI:10.376/cma.j.issn.0254-6450.2017.02.015.
[2] Liu M, Wang J, Jiang B, et al. Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001-2010[J]. PLoS One, 2013,8(6):e66233. DOI:10.1371/journal.pone.0066233.
[3] D'Elia L, Barba G, Cappuccio FP, et al. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies[J]. J Am Coll Cardiol, 2011,57(10):1210-1219. DOI:10.1016/j.clnu.2018.05.017.
[4] Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women[J]. Arch Intern Med, 2004,164(10):1066-1076. DOI:10.1001/archinte.164.10.1066.
[5] Chatterjee R, Yeh HC, Shafi T, et al. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities(ARIC)Study[J]. Am J Clin Nutr, 2011,93(5):1087-1091. DOI:10.1007/s11606-013-2569-z.
[6] Mariosa LS, Ribeiro-Filho FF, Batista MC, et al. Abdominal obesity is associated with potassium depletion and changes in glucose homeostasis during diuretic therapy[J]. J Clin Hypertens(Greenwich), 2008,10(6):443-449. DOI:10.1111/j.1751-7176.2008.07817.x.
[7] Shin D, Joh HK, Kim KH, et al. Benefits of potassium intake on metabolic syndrome: the fourth Korean National Health and Nutrition Examination Survey(KNHANES Ⅳ)[J]. Atherosclerosis,2013,230(1):80-85. DOI:10.1016/j.atherosclerosis.2013.06.025.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018,10(1):4-67. DOI:10.19538/j.nk2018040108.
[9] 程义勇. 《中国居民膳食营养素参考摄入量》2013修订版简介[J]. 营养学报, 2014,36(4):313-317. DOI:10.13325/j.cnki.acta.nutr.sin.2014.04.002.
[10] 于冬梅, 何宇纳, 郭齐雅, 等. 2002-2012年中国居民能量营养素摄入状况及变化趋势[J]. 卫生研究, 2016,45(4):527-533. DOI:10.3760/cma.j.issn.0254-6450.2017.02.015.
[11] Lee H, Lee J, Hwang SS, et al. Potassium intake and the prevalence of metabolic syndrome: the Korean National Health and Nutrition Examination Survey 2008-2010[J]. PLoS One, 2013,8(1):e55106. DOI:10.1371/journal.pone.0055106.
[12] Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007[J]. Diabetes Care, 2011,34(6):1323-1328. DOI:10.2337/dc10-2109.
[13] Yan F, Liu J, Zhao X, et al. Association of the number of years since menopause with metabolic syndrome and insulin resistance in Chinese urban women[J].J Womens Health(Larchmt),2015,24(10):843-848. DOI:10.1089/jwh.2014.5183.
[14] 高丽虹, 孙爱军. 绝经后代谢综合征研究进展[J].生殖医学杂志, 2019,28(6):702-706. DOI:10.3969/j.issn.1004-3845.2019.06.023.
[15] Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease:systematic review and meta-analyses[J]. BMJ, 2013,346:f1378. DOI:10.1136/bmj.f1378.
[16] Rowe JW, Tobin JD, Rosa RM, et al. Effect of experimental potassium deficiency on glucose and insulin metabolism[J]. Metabolism, 1980,29(6):498-502. DOI:10.1016/0026-0495(80)90074-8.
[17] Norbiato G, Bevilacqua M, Meroni R, et al. Effects of potassium supplementation on insulin binding and insulin action in human obesity:protein-modified fast and refeeding[J]. Eur J Clin Invest, 1984,14(6):414-419. DOI:10.1111/j.1365-2362.1984.tb01205.x.
[18] Tal B, Sack J, Yaron M, et al. Increment in dietary potassium predicts weight loss in the treatment of the metabolic syndrome[J]. Nutrients, 2019,11(6). DOI:10.3390/nu11061256.
[19] Upadhyay SK, Eckel-Mahan KL, Mirbolooki MR, et al. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance[J]. Proc Natl Acad Sci U S A, 2013,110(24):E2239-E2248. DOI:10.1073/pnas.1221206110.
[20] Crunkhorn S. Metabolic disease: potassium channel blocker prevents obesity[J]. Nat Rev Drug Discov, 2013,12(8):577. DOI:10.1038/nrd4081.
[21] Fallo F, Della MP, Sonino N, et al. Adiponectin and insulin sensitivity in primary aldosteronism[J]. Am J Hypertens, 2007,20(8):855-861. DOI:10.1016/j.amjhyper.2007.03.012.
[22] Norbiato G, Bevilacqua M, Meroni R, et al. Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein-modified fast and refeeding[J]. Eur J Clin Invest, 1984,14(6):414-419. DOI:10.1111/j.1365-2362.1984.tb01205.x.

相似文献/References:

[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(03):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨雪,时立新,张巧,等.中老年人群25-羟维生素D3与代谢综合征的 相关性分析[J].国际内分泌代谢杂志,2014,(05):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
　Yang Xue*,Shi Lixin,Zhang Qiao,et al.Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population[J].International Journal of Endocrinology and Metabolism,2014,(03):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(03):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]王姝洁,张翼飞,张志国.雷公藤红素在治疗代谢综合征中的作用及相关机制[J].国际内分泌代谢杂志,2017,37(04):258.
　Wang Shujie,Zhang Yifei,Zhang Zhiguo..Effects and related mechanisms of celastrol in the treatment of metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(03):258.
[5]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
　Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(03):270.
[6]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
　Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(03):298.
[7]谢幸 陈树春 朱海娇 刘阳 王幸.蛙皮素样受体亚型-3与代谢综合征[J].国际内分泌代谢杂志,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
　Xie Xing*,Chen Shuchun,Zhu Haijiao,et al.Bombesin receptor subtype-3 and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
[8]聂秀玲.长期果糖摄入与代谢综合征[J].国际内分泌代谢杂志,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
　Nie Xiuling.Chronic fructose intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(03):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
[9]肖扬 徐书杭 黄华英 郭玲 吕文君 冯宁霞 汪奇峰 茅晓东 陈国芳 刘超.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
　Xiao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(03):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[10]王应昉 曹璐 陈凤 许帅 陈风 郭妍 王岩 王涤非.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]
　Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community elderly residents[J].International Journal of Endocrinology and Metabolism,2020,40(03):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]

备注/Memo

备注/Memo:
通信作者:闫妮,Email:275624756@qq.com
Corresponding author: Yan Ni, Email: 275624756@qq.com
更新日期/Last Update: 2020-05-20